Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy (Q44989652)

8 December 2017

title

Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy (English)

1 reference

8 December 2017

1 reference

metastatic colon cancer

1 reference

3

Narikazu Boku

1 reference

8 December 2017

Madoka Takao

1

1 reference

8 December 2017

Kentaro Yamazaki

2

1 reference

8 December 2017

Hisatomo Ikehara

4

1 reference

8 December 2017

Satoshi Hamauchi

5

1 reference

8 December 2017

Takahiro Tsushima

6

1 reference

8 December 2017

Hiroya Taniguchi

7

1 reference

8 December 2017

Akiko Todaka

8

1 reference

8 December 2017

Nozomu Machida

9

1 reference

8 December 2017

Akira Fukutomi

10

1 reference

8 December 2017

Yusuke Onozawa

11

1 reference

8 December 2017

Hirofumi Yasui

12

1 reference

8 December 2017

publication date

7 August 2012

1 reference

International Journal of Clinical Oncology

8 December 2017

published in

1 reference

8 December 2017

volume

18

1 reference

8 December 2017

issue

5

1 reference

8 December 2017

page(s)

864-868

1 reference

Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0452-2

Use of surgery among elderly patients with stage IV colorectal cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22865286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22865286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Palliative resection of colorectal cancer: does it prolong survival?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22865286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10147-012-0452-2

1 reference

8 December 2017

1 reference